These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38016679)

  • 1. Ultrafast MRI and T1 and T2 Radiomics for Predicting Invasive Components in Ductal Carcinoma in Situ Diagnosed With Percutaneous Needle Biopsy.
    Kim MY; Yoen H; Ji H; Park SJ; Kim SM; Han W; Cho N
    Korean J Radiol; 2023 Dec; 24(12):1190-1199. PubMed ID: 38016679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.
    Mori N; Abe H; Mugikura S; Miyashita M; Mori Y; Oguma Y; Hirasawa M; Sato S; Takase K
    Breast Cancer; 2021 Sep; 28(5):1141-1153. PubMed ID: 33900583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI-Based Radiomics.
    Hong M; Fan S; Yu Z; Gao C; Fang Z; Du L; Wang S; Chen X; Xu M; Zhou C
    J Magn Reson Imaging; 2023 Aug; 58(2):454-463. PubMed ID: 36440711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging.
    Miceli R; Gao Y; Qian K; Heller SL
    AJR Am J Roentgenol; 2023 Jul; 221(1):34-43. PubMed ID: 36752370
    [No Abstract]   [Full Text] [Related]  

  • 5. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
    Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
    Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Performance of Radiomic Features Extracted from Breast MR Imaging in Postoperative Upgrading of Ductal Carcinoma in Situ to Invasive Carcinoma.
    Satake H; Kinoshita F; Ishigaki S; Kato K; Jo Y; Shimada S; Masuda N; Naganawa S
    Magn Reson Med Sci; 2024 May; ():. PubMed ID: 38749758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
    Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility analysis of magnetic resonance imaging-based radiomics features for preoperative prediction of nuclear grading of ductal carcinoma in situ.
    Zhao MR; Ma WJ; Song XC; Li ZJ; Shao ZZ; Lu H; Zhao R; Guo YJ; Ye ZX; Liu PF
    Gland Surg; 2023 Sep; 12(9):1209-1223. PubMed ID: 37842532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.
    Hou R; Grimm LJ; Mazurowski MA; Marks JR; King LM; Maley CC; Lynch T; van Oirsouw M; Rogers K; Stone N; Wallis M; Teuwen J; Wesseling J; Hwang ES; Lo JY
    Radiology; 2022 Apr; 303(1):54-62. PubMed ID: 34981975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.
    Lee SA; Lee Y; Ryu HS; Jang MJ; Moon WK; Moon HG; Lee SH
    Radiology; 2022 Nov; 305(2):307-316. PubMed ID: 35787199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.
    Lee KH; Han JW; Kim EY; Yun JS; Park YL; Park CH
    BMC Cancer; 2019 Dec; 19(1):1201. PubMed ID: 31822268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study.
    Huang Z; Chen X; Jiang N; Hu S; Hu C
    BMC Med Imaging; 2023 Sep; 23(1):118. PubMed ID: 37679713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.
    Shin HJ; Choi WJ; Park SY; Ahn SH; Son BH; Chung IY; Lee JW; Ko BS; Kim JS; Chae EY; Cha JH; Kim HH
    Clin Breast Cancer; 2022 Apr; 22(3):e374-e386. PubMed ID: 34776365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
    Harowicz MR; Saha A; Grimm LJ; Marcom PK; Marks JR; Hwang ES; Mazurowski MA
    J Magn Reson Imaging; 2017 Nov; 46(5):1332-1340. PubMed ID: 28181348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
    Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
    Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
    Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
    Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of ultrafast MRI evaluation for predicting histologic upgrade of ductal carcinoma in situ.
    Heo S; Park AY; Jung HK; Ko KH; Kim Y; Koh J
    Eur J Radiol; 2021 Mar; 136():109519. PubMed ID: 33429208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.